These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 30564555)

  • 1. Notch Signaling Regulates Mitochondrial Metabolism and NF-κB Activity in Triple-Negative Breast Cancer Cells via IKKα-Dependent Non-canonical Pathways.
    Hossain F; Sorrentino C; Ucar DA; Peng Y; Matossian M; Wyczechowska D; Crabtree J; Zabaleta J; Morello S; Del Valle L; Burow M; Collins-Burow B; Pannuti A; Minter LM; Golde TE; Osborne BA; Miele L
    Front Oncol; 2018; 8():575. PubMed ID: 30564555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Notch1, pAKT and nuclear NF-κB expression in triple negative breast cancer.
    Zhu H; Bhaijee F; Ishaq N; Pepper DJ; Backus K; Brown AS; Zhou X; Miele L
    Am J Cancer Res; 2013; 3(2):230-9. PubMed ID: 23593544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL6 and the Notch pathway: a signaling axis leading to a novel druggable biotarget in triple negative breast cancer.
    De Santis F; Romero-Cordoba SL; Castagnoli L; Volpari T; Faraci S; Fucà G; Tagliabue E; De Braud F; Pupa SM; Di Nicola M
    Cell Oncol (Dordr); 2022 Apr; 45(2):257-274. PubMed ID: 35357654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bruceine D suppresses CAF-promoted TNBC metastasis under TNF-α stimulation by inhibiting Notch1-Jagged1/NF-κB(p65) signaling.
    Chen H; Han X; Zhang Y; Wang K; Liu D; Hu Z; Wang J
    Phytomedicine; 2024 Jan; 123():154928. PubMed ID: 38043386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell Population.
    Bhola NE; Jansen VM; Koch JP; Li H; Formisano L; Williams JA; Grandis JR; Arteaga CL
    Cancer Res; 2016 Jan; 76(2):440-52. PubMed ID: 26676751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HER2 Increases JAGGED1-dependent Breast Cancer Stem Cells: Role for Membrane JAGGED1.
    Shah D; Wyatt D; Baker AT; Simms P; Peiffer DS; Fernandez M; Rakha E; Green A; Filipovic A; Miele L; Osipo C
    Clin Cancer Res; 2018 Sep; 24(18):4566-4578. PubMed ID: 29895705
    [No Abstract]   [Full Text] [Related]  

  • 7. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.
    Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A
    Front Immunol; 2019; 10():804. PubMed ID: 31105691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer.
    Hossain F; Ucar DA; Monticone G; Ran Y; Majumder S; Larter K; Luu H; Wyczechowska D; Heidari S; Xu K; Shanthalingam S; Matossian M; Xi Y; Burow M; Collins-Burow B; Del Valle L; Hicks C; Zabaleta J; Golde T; Osborne B; Miele L
    Front Immunol; 2023; 14():1244159. PubMed ID: 37901240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch-1 signaling activates NF-κB in human breast carcinoma MDA-MB-231 cells via PP2A-dependent AKT pathway.
    Li L; Zhang J; Xiong N; Li S; Chen Y; Yang H; Wu C; Zeng H; Liu Y
    Med Oncol; 2016 Apr; 33(4):33. PubMed ID: 26945854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun.
    Xie X; Kaoud TS; Edupuganti R; Zhang T; Kogawa T; Zhao Y; Chauhan GB; Giannoukos DN; Qi Y; Tripathy D; Wang J; Gray NS; Dalby KN; Bartholomeusz C; Ueno NT
    Oncogene; 2017 May; 36(18):2599-2608. PubMed ID: 27941886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells.
    Sulaiman A; McGarry S; Lam KM; El-Sahli S; Chambers J; Kaczmarek S; Li L; Addison C; Dimitroulakos J; Arnaout A; Nessim C; Yao Z; Ji G; Song H; Liu S; Xie Y; Gadde S; Li X; Wang L
    Cell Death Dis; 2018 Jul; 9(8):815. PubMed ID: 30050079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rel/NF-kappaB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors.
    Bash J; Zong WX; Banga S; Rivera A; Ballard DW; Ron Y; Gélinas C
    EMBO J; 1999 May; 18(10):2803-11. PubMed ID: 10329626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF-2α regulates CD44 to promote cancer stem cell activation in triple-negative breast cancer
    Bai J; Chen WB; Zhang XY; Kang XN; Jin LJ; Zhang H; Wang ZY
    World J Stem Cells; 2020 Jan; 12(1):87-99. PubMed ID: 32110277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Notch1 and IKKα Enhanced NF-κB Activation in CD133
    Quan XX; Hawk NV; Chen W; Coupar J; Lee SK; Petersen DW; Meltzer PS; Montemarano A; Braun M; Chen Z; Van Waes C
    Mol Cancer Ther; 2018 Sep; 17(9):2034-2048. PubMed ID: 29959199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch1 promotes glioma cell migration and invasion by stimulating β-catenin and NF-κB signaling via AKT activation.
    Zhang X; Chen T; Zhang J; Mao Q; Li S; Xiong W; Qiu Y; Xie Q; Ge J
    Cancer Sci; 2012 Feb; 103(2):181-90. PubMed ID: 22093097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-stressed cardiomyocytes promote early cardiac differentiation of cardiac stem cells through HIF-1
    Wang K; Ding R; Ha Y; Jia Y; Liao X; Wang S; Li R; Shen Z; Xiong H; Guo J; Jie W
    Acta Pharm Sin B; 2018 Sep; 8(5):795-804. PubMed ID: 30245966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual inhibition of Wnt and Yes-associated protein signaling retards the growth of triple-negative breast cancer in both mesenchymal and epithelial states.
    Sulaiman A; McGarry S; Li L; Jia D; Ooi S; Addison C; Dimitroulakos J; Arnaout A; Nessim C; Yao Z; Ji G; Song H; Gadde S; Li X; Wang L
    Mol Oncol; 2018 Apr; 12(4):423-440. PubMed ID: 29316250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts.
    House CD; Grajales V; Ozaki M; Jordan E; Wubneh H; Kimble DC; James JM; Kim MK; Annunziata CM
    BMC Cancer; 2018 May; 18(1):595. PubMed ID: 29801480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.